EI
REGN icon

Ellevest Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Ellevest Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$488K Sell
631
-278
-31% -$213K 0.07% 237
2025
Q4 		$702K Sell
909
-202
-18% -$137K 0.1% 152
2025
Q3 		$625K Buy
1,111
+260
+31% +$147K 0.09% 168
2025
Q2 		$447K Buy
851
+464
+120% +$259K 0.07% 217
2025
Q1 		$245K Sell
387
-155
-29% -$107K 0.02% 334
2024
Q4 		$386K Buy
542
+202
+59% +$170K 0.02% 256
2024
Q3 		$357K Buy
340
+33
+11% +$36.7K 0.02% 288
2024
Q2 		$323K Sell
307
-6
-2% -$5.82K 0.02% 305
2024
Q1 		$301K Buy
313
+4
+1% +$3.8K 0.02% 311
2023
Q4 		$271K Sell
309
-75
-20% -$61.8K 0.02% 313
2023
Q3 		$316K Sell
384
-232
-38% -$182K 0.02% 255
2023
Q2 		$443K Buy
616
+127
+26% +$97.9K 0.03% 177
2023
Q1 		$402K Buy
489
+81
+20% +$61.1K 0.03% 180
2022
Q4 		$294K Buy
408
+11
+3% +$8.12K 0.02% 235
2022
Q3 		$273K Sell
397
-43
-10% -$27.1K 0.03% 207
2022
Q2 		$260K Buy
440
+6
+1% +$3.9K 0.02% 232
2022
Q1 		$303K Buy
434
+207
+91% +$131K 0.03% 235
2021
Q4 		$143K Buy
227
+1
+0.4% +$615 0.01% 342
2021
Q3 		$137K Buy
226
+33
+17% +$20.5K 0.01% 343
2021
Q2 		$108K Buy
193
+178
+1,187% +$90.2K 0.01% 361
2021
Q1 		$7K Sell
15
-175
-92% -$85.2K ﹤0.01% 850
2020
Q4 		$92K Buy
190
+38
+25% +$20.5K 0.01% 329
2020
Q3 		$85K Sell
152
-4
-3% -$2.42K 0.02% 297
2020
Q2 		$97K Buy
156
+127
+438% +$72.1K 0.02% 215
2020
Q1 		$14K Buy
29
+18
+164% +$7.42K ﹤0.01% 493
2019
Q4 		$4K Buy
11
+2
+22% +$673 ﹤0.01% 622
2019
Q3 		$2K Buy
+9
New +$2.66K ﹤0.01% 348

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ellevest Inc's REGN Position: Q1 2026 in Review

Ellevest Inc reduced its Regeneron Pharmaceuticals (REGN) stake by 31% in Q1 2026, selling an estimated $213K and leaving 631 shares worth $488K. The position accounts for 0.07% of the portfolio, ranked #237.

Ellevest Inc first reported a position in REGN in Q3 2019 and has held it in 27 quarters since. The position peaked at $702K in Q4 2025. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Ellevest Inc held 631 shares of Regeneron Pharmaceuticals worth $488K as of Q1 2026.
  • Ellevest Inc sold 278 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $213K.
  • Regeneron Pharmaceuticals made up 0.07% of Ellevest Inc's portfolio in Q1 2026, its #237 holding.
  • Ellevest Inc first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 27 quarters since.
  • Ellevest Inc's Regeneron Pharmaceuticals position peaked at $702K in Q4 2025.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Ellevest Inc's 13F filing for Q1 2026, filed 11 May 2026.